论文部分内容阅读
目的分析冠心病检测中不同血液检验指标的临床应用价值。方法回顾性分析2013年5月—2015年5月收治的90例冠心病患者的临床资料,其中40例心绞痛患者作为a组,50例急性心肌梗死患者作为b组,另选同期健康体检者30例作为c组。观察并比较三组PCT、MPV、PDW、PLT、RDW及CK-MB、c Tn I、c Tn T、hs-c Tn T的测定结果。计量资料采用t检验,P<0.05为差异有统计学意义。结果 c组RDW水平为(13.08±0.53)%,低于a组和b组的(13.78±0.75)%、(14.12±1.41)%,差异均有统计学意义(均P<0.05)。c组CK-MB、c Tn I、c Tn T、hs-c Tn T水平分别为(11.02±5.06)IU/L、(0.00±0.00)、(0.00±0.00)、(0.00±0.00)μg/L,均低于a组的(15.01±7.03)IU/L、(0.06±0.05)、(0.03±0.02)、(0.02±0.01)μg/L与b组的(152.02±103.05)IU/L、(16.55±7.96)、(0.06±0.01)、(3.06±1.21)μg/L,差异均有统计学意义(均P<0.05)。结论 RDW水平升高可作为判断冠心病患者不良预后的危险指标,c Tn I水平是判断心肌受损的较好指标。
Objective To analyze the clinical value of different blood tests in coronary heart disease. Methods The clinical data of 90 patients with coronary heart disease admitted from May 2013 to May 2015 were retrospectively analyzed. Among them, 40 patients with angina pectoris as group a and 50 patients with acute myocardial infarction as group b, Example as c group. The results of PCT, MPV, PDW, PLT, RDW and CK-MB, cTn I, c Tn T, hs-c Tn T were observed and compared. Measurement data using t test, P <0.05 for the difference was statistically significant. Results The level of RDW in group c was (13.08 ± 0.53)%, which was lower than that in group a and b (13.78 ± 0.75)% and (14.12 ± 1.41)%, respectively (all P <0.05). The levels of CK-MB, c Tn I, c Tn T and hs-c Tn T in group C were (11.02 ± 5.06) IU / L and (0.00 ± 0.00) L were significantly lower than those in group a (15.01 ± 7.03) IU / L, (0.06 ± 0.05), (0.03 ± 0.02), (0.02 ± 0.01) μg / L and 152.02 ± 103.05 IU / (16.55 ± 7.96), (0.06 ± 0.01) and (3.06 ± 1.21) μg / L, respectively (all P <0.05). Conclusions The elevated RDW level can be used as a risk indicator to judge the adverse prognosis of patients with coronary heart disease. The level of cTnI is a good indicator to judge the myocardial damage.